Skip to content

Adicet Bio, Inc.

ACET

CIK 0001720580 · Pharmaceutical Preparations · Nasdaq

  • resTORbio, Inc. (until 2020-08-21)
← back to feed
Revenue (TTM)
—
FY May 2026
Net Income (TTM)
−$106.53M
+0.3% YoY FY May 2026
EPS Diluted (TTM)
−$7.47
+20.5% YoY FY May 2026
Gross Margin
—
FY May 2026
Operating Margin
—
FY May 2026
Net Margin
—
FY May 2026
Free Cash Flow (TTM)
−$97.51M
FY May 2026
Cash
$36.25M
FY May 2026
Total Debt
—
FY May 2026
Shares Outstanding
9.35M sh
FY May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings